Markets:

Overview

News

Currencies

International

Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

13.76 -0.21 (-1.54%)

Streaming Delayed Price Updated: 12:25 PM EDT, Mar 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Here's How You Can Collect $100 in Dividends Every Month ↗

April 05, 2023

These dividend stocks can be excellent sources of recurring cash flow for years.

Via The Motley Fool

The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat ↗

April 05, 2023

Millions of people are scrambling to get their ADHD medication. Here's why.

Via Investor's Business Daily

The 7 Most Undervalued Nasdaq Stocks to Buy in April 2023 ↗

April 04, 2023

Each of these seven undervalued Nasdaq stocks have catalysts in play that could help bridge their respective valuation gaps.

Via InvestorPlace

Which Is the Better Dividend Stock: Viatris or Apple? ↗

March 31, 2023

One has a higher dividend yield, but there's more to the story.

Via The Motley Fool

Coinbase Says US 1M Tech Jobs At Risk, Microsoft To Place Ads In ChatGPT Powered Bing Search, Netflix Preps For Big Transition Into TV Gaming: Today's Top Stories ↗

March 30, 2023

Benzinga

Via Benzinga

Is Viatris' 5% Dividend Yield Safe? ↗

March 21, 2023

Should you buy this beaten-down dividend stock?

Via The Motley Fool

Viatris's Ex-Dividend Date Is Wednesday, Here's What You Need To Know ↗

March 03, 2023

Via Benzinga

Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug ↗

March 30, 2023

Via Benzinga

Don't Be Fooled by These 3 Value Traps

March 28, 2023

Approximately one out of every ten U.S. listed stocks have a positive P/E ratio less than 10. Some are justifiably cheap; others are merely fool’s gold.

Via MarketBeat

3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential ↗

March 26, 2023

These three spinoffs are already profitable.

Via The Motley Fool

I Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch. ↗

March 25, 2023

It isn't an easy decision to choose the best among this group of dividend stocks.

Via The Motley Fool

Use These 3 Strategies to Make $1,000 in Passive Income Per Year ↗

March 23, 2023

It's worth having these approaches in your investor toolkit.

Via The Motley Fool

4 Analysts Have This to Say About Viatris ↗

February 28, 2023

Via Benzinga

Earnings Preview: Viatris ↗

February 24, 2023

Via Benzinga

BMO Downgrades Viatris As Its Looks For More Visibility On Next Phase ↗

February 17, 2023

Via Benzinga

Nasdaq Bear Market: These 3 Stocks Are Trading Below Their Book Values ↗

March 14, 2023

Analysts are bullish on all of these stocks.

Via The Motley Fool

Better Generics Pharmaceutical Stock: Teva or Viatris? ↗

March 05, 2023

Both have plans to return to growth.

Via The Motley Fool

2 Undervalued Growth Stocks With Long-Term Prospects That Are Ready to Rise ↗

March 02, 2023

There's nothing better than getting a bargain that'll pay off for years.

Via The Motley Fool

Why Is Intuitive Machines (LUNR) Stock Up Today? ↗

February 27, 2023

Intuitive Machines (LUNR) stock is climbing higher on Monday thanks to new coverage from Canaccord analyst Austin Moeller.

Via InvestorPlace

Is Warren Buffett Going to Buy Tesla (TSLA) Stock? ↗

February 27, 2023

Warren Buffett and Tesla (TSLA) stock are hot topics among traders on Monday following a series of Tweets about buying the shares.

Via InvestorPlace

VTRS Stock Alert: What to Know as Viatris Appoints New CEO ↗

February 27, 2023

Viatris (VTRS) stock is in the news Monday after the healthcare company announced Scott Smith is taking over as its next CEO.

Via InvestorPlace

BioAtla Announces Change in Executive Leadership

February 27, 2023

From BioAtla, Inc.

Via GlobeNewswire

2 Dividend Stocks to Buy at a Discounted Price In 2023 ↗

February 27, 2023

Their shares are ripe for getting while the getting is good.

Via The Motley Fool

Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk ↗

February 27, 2023

US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could...

Via Benzinga

2 Superb Dividend Stocks to Buy Before the Next Bull Market ↗

February 21, 2023

There might not be an opportunity to get them for much cheaper than now.

Via The Motley Fool

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later ↗

February 18, 2023

These pharmaceutical stocks probably won't stay so attractively valued for too much longer.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗

February 17, 2023

Via Benzinga

NVIDIA To Rally Around Over 30%? Here Are 10 Other Analyst Forecasts For Friday ↗

February 17, 2023

Keybanc boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $220 to $280. Keybanc analyst John Vinh maintained an Overweight rating on the stock. NVIDIA shares fell 1.7% to $216.22 in...

Via Benzinga

These Are 3 of the Nasdaq's Cheapest Dividend Stocks ↗

February 15, 2023

These stocks can be good options whether you value dividends or growth.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.